In this report, we've selected ten leading pharma companies in Istanbul and examined their patent portfolio. You can make your own analysis and follow your competitors in your private workspaces.
- Abdi İbrahim
- Arven İlaç
- Ali Arif İlaç
- Berko İlaç
- World Medicine İlaç
- Biofarma ilaç
- Mustafa Nevzat ilaç
- İmuneks Farma
- Era Pharma
- Example: Arven Portfolio analysis
- Potential university collaboration opportunities of the firm in the respiratory field
- Potential cooperation and licensee information in the respiratory field
- Sample international company investment activities
The Innovation Rate graph shows the annual patenting trend in the technology field.
The territory map shows the breakdown of patents across jurisdictions on the subject technology field. The territory map is useful visual tool that shows key markets where patent applicants on the subject technology field focus on.
The graph shows the technology areas by their IPC codes on the left X-axis. Y-axis corresponds to the period of search. This visualization shows the yearly patenting trends in the subject technology field by year. In an emerging technology area, the number of activity will grow over the years. Conversely, a declining technology area will show less patenting activity over the years.
Analyze the technology focus of the selected organizations. Visual shows the presence of the organizations in different technology fields. It helps you to understand where organizations invest to build their portfolio.
The graph shows the top inventors in the technology field. This information is useful for identifying the key performers for collaboration or for recruiting inventors.
|Publication Number||Title (Translated)||# of Cited by|
|EP2666498A1||Inhaler device having an improved guide gear||5|
|EP2682108A2||Dry Powder Inhalers Comprising a Carrier Other Than Lactose and a Ternary Component||5|
|USD737424S1||Button of an inhaler device||4|
|USD745138S1||Member of an inhaler device||4|
|US20150165037A1||Inhalation compositions comprising corticosteroid and sorbitol||3|
|WO2013176643A1||Blister advancement mechanism comprising an actuator plate||3|
|WO2014007772A2||Inhalation compositions comprising glucose anhydrous||3|
|US20150165038A1||Compositions comprising muscarinic receptor antagonist and sorbitol||2|
Prior Technology Classifications
A61M15 : Inhaling devices
A61K31 : Medicinal preparations containing organic active ingredients
A61K9: Medicinal preparations characterised by special physical form
See what you can do with interactive reports!